Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Diffusion Pharmaceuticals stock

Own Diffusion Pharmaceuticals stock in just a few minutes.

Diffusion Pharmaceuticals Inc is a biotechnology business based in the US. Diffusion Pharmaceuticals shares (DFFN) are listed on the NASDAQ and all prices are listed in US Dollars. Diffusion Pharmaceuticals employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Diffusion Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DFFN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Diffusion Pharmaceuticals share price

Use our graph to track the performance of DFFN stocks over time.

Diffusion Pharmaceuticals shares at a glance

Information last updated 2021-04-30.
52-week range$0.48 - $1.85
50-day moving average $0.87
200-day moving average $0.93
Wall St. target price$2.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-4.97

Buy Diffusion Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
$0
Stocks, Options, ETFs
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Webull
$0
Stocks, Options, ETFs
$0
0%
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Public
$0
Stocks, ETFs
N/A
$0 per month
N/A
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Diffusion Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Diffusion Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -38.52%
Return on equity TTM -63.12%
Profit margin 0%
Book value $0.39
Market capitalisation $79.9 million

TTM: trailing 12 months

Shorting Diffusion Pharmaceuticals shares

There are currently 2.8 million Diffusion Pharmaceuticals shares held short by investors – that's known as Diffusion Pharmaceuticals's "short interest". This figure is 7.3% up from 2.6 million last month.

There are a few different ways that this level of interest in shorting Diffusion Pharmaceuticals shares can be evaluated.

Diffusion Pharmaceuticals's "short interest ratio" (SIR)

Diffusion Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Diffusion Pharmaceuticals shares currently shorted divided by the average quantity of Diffusion Pharmaceuticals shares traded daily (recently around 2.5 million). Diffusion Pharmaceuticals's SIR currently stands at 1.14. In other words for every 100,000 Diffusion Pharmaceuticals shares traded daily on the market, roughly 1140 shares are currently held short.

However Diffusion Pharmaceuticals's short interest can also be evaluated against the total number of Diffusion Pharmaceuticals shares, or, against the total number of tradable Diffusion Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Diffusion Pharmaceuticals's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Diffusion Pharmaceuticals shares in existence, roughly 30 shares are currently held short) or 0.0275% of the tradable shares (for every 100,000 tradable Diffusion Pharmaceuticals shares, roughly 28 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Diffusion Pharmaceuticals.

Find out more about how you can short Diffusion Pharmaceuticals stock.

Diffusion Pharmaceuticals share dividends

We're not expecting Diffusion Pharmaceuticals to pay a dividend over the next 12 months.

Have Diffusion Pharmaceuticals's shares ever split?

Diffusion Pharmaceuticals's shares were split on a 1:15 basis on 13 December 2018. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Diffusion Pharmaceuticals shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for Diffusion Pharmaceuticals shares which in turn could have impacted Diffusion Pharmaceuticals's share price.

Diffusion Pharmaceuticals share price volatility

Over the last 12 months, Diffusion Pharmaceuticals's shares have ranged in value from as little as $0.48 up to $1.85. A popular way to gauge a stock's volatility is its "beta".

DFFN.US volatility(beta: 1.66)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Diffusion Pharmaceuticals's is 1.6646. This would suggest that Diffusion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Diffusion Pharmaceuticals overview

Diffusion Pharmaceuticals Inc. , a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. .

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site